Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Ställberg, E. B. C. Andersson, T. Ekström, O. Selroos, C. Vogelmeier, K. Larsson (Uppsala, Södertälje, Lund, Stockholm, Sweden; Marburg, Germany). Budesonide/formoterol for the treatment of COPD exacerbations in the primary healthcare setting. Eur Respir J 2008; 32: Suppl. 52, 3610

Member's Comments

No comment yet.

Related content which might interest you: COPD exacerbation and primary care physicians Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Budesonide/formoterol added to tiotropium improves exacerbations and exacerbation-related antibiotic use in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 The impact of implementing a COPD care bundle on the delivery of care to patients admitted with an acute exacerbation of COPD Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Physician consultation and outcomes of treatment in exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations Source: Eur Respir Rev 2006; 15: 47-51 Year: 2006 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 A highly complex home care service for COPD in LTOT may reduce the exacerbations and the hospitalizations Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Could a domiciliary COPD care management programme be cost-effective in severe COPD patients? Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005 Provision of self-management plans for treatment of COPD exacerbations reduce hospital admissions Source: Eur Respir J 2007; 30: Suppl. 51, 569s Year: 2007 Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Can the organisation of COPD care in primary health care centres help preventing exacerbations in COPD patients? Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012 Treatment of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 235s Year: 2001 Manner of treatment and costs of COPD exacerbations in secondary medical care in Poland Source: Eur Respir J 2007; 30: Suppl. 51, 194s Year: 2007 Provision of care for acute COPD in UK hospitals: survey of acute NIV provision for COPD exacerbations Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Optimising inpatient resources: role of a domiciliary COPD care management programme Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005 Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002